Lazard Asset Management
AMN icon

Lazard Asset Management’s AMN Healthcare AMN Stock Holding History

Lazard Asset Management’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.92M Buy
151,866
+140,811
+1,274% +$3.63M 0.01% 628
2026
Q1 		$203K Buy
+11,055
New +$210K ﹤0.01% 1629
2024
Q2 		– Sell
-4,075
Closed -$254K – 2220
2024
Q1 		$254K Sell
4,075
-31,860
-89% -$2.17M ﹤0.01% 1228
2023
Q4 		$2.69M Buy
35,935
+4,193
+13% +$300K ﹤0.01% 801
2023
Q3 		$2.7M Sell
31,742
-6,276
-17% -$595K ﹤0.01% 820
2023
Q2 		$4.15M Sell
38,018
-20,777
-35% -$1.97M 0.01% 742
2023
Q1 		$4.88M Sell
58,795
-79,420
-57% -$7.48M 0.01% 734
2022
Q4 		$14.2M Sell
138,215
-14,823
-10% -$1.71M 0.02% 500
2022
Q3 		$16.2M Sell
153,038
-29,044
-16% -$3.18M 0.02% 461
2022
Q2 		$20M Buy
182,082
+98,835
+119% +$9.78M 0.03% 432
2022
Q1 		$8.68M Buy
83,247
+4,709
+6% +$489K 0.01% 648
2021
Q4 		$9.61M Sell
78,538
-6,550
-8% -$727K 0.01% 639
2021
Q3 		$9.76M Buy
85,088
+28,053
+49% +$2.97M 0.01% 631
2021
Q2 		$5.53M Buy
+57,035
New +$4.95M 0.01% 711
2020
Q3 		– Sell
-659
Closed -$29K – 1600
2020
Q2 		$29K Buy
659
+56
+9% +$2.68K ﹤0.01% 1375
2020
Q1 		$34K Buy
603
+136
+29% +$9.31K ﹤0.01% 1311
2019
Q4 		$29K Buy
+467
New +$27.6K ﹤0.01% 1159
2018
Q2 		– Sell
-532,846
Closed -$30.2M – 1030
2018
Q1 		$30.2M Sell
532,846
-195,395
-27% -$10.6M 0.05% 243
2017
Q4 		$35.9M Sell
728,241
-160,267
-18% -$7.3M 0.06% 213
2017
Q3 		$40.6M Buy
888,508
+34,819
+4% +$1.33M 0.07% 184
2017
Q2 		$33.3M Buy
853,689
+281,722
+49% +$10.8M 0.06% 212
2017
Q1 		$23.2M Buy
+571,967
New +$22.4M 0.04% 270
2016
Q2 		– Sell
-40
Closed -$1K – 1036
2016
Q1 		$1K Sell
40
-5,870
-99% -$168K ﹤0.01% 1007
2015
Q4 		$183K Buy
+5,910
New +$175K ﹤0.01% 833

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Lazard Asset Management's AMN Position: Q2 2026 in Review

Lazard Asset Management increased its AMN Healthcare (AMN) stake by 1,274% in Q2 2026, buying an estimated $3.63M and bringing the position to 151,866 shares worth $4.92M. The position accounts for 0.01% of the portfolio, ranked #628.

Lazard Asset Management first reported a position in AMN in Q4 2015 and has held it in 24 quarters since. The position peaked at $40.6M in Q3 2017. 285 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Lazard Asset Management held 151,866 shares of AMN Healthcare worth $4.92M as of Q2 2026.
  • Lazard Asset Management bought 140,811 AMN Healthcare shares in Q2 2026, an estimated $3.63M.
  • AMN Healthcare made up 0.01% of Lazard Asset Management's portfolio in Q2 2026, its #628 holding.
  • Lazard Asset Management first reported a position in AMN Healthcare in Q4 2015 and has held it in 24 quarters since.
  • Lazard Asset Management's AMN Healthcare position peaked at $40.6M in Q3 2017.
  • 285 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.